Sjogren's syndrome is an autoimmune disease characterised by lymphoplasmocytic infiltration of exocrine glands and numerous organ and nonorgan-specific autoantibodies.' The syndrome occurs alone (primary) or in association with other autoimmune rheumatic diseases (secondary), most Fig. 3 shows the results of HLA typing in the third family with Ss. In this family the 2 affected individuals shared the C haplotype, HLA Aw23, Bw38, DRw6, and MT1. The maternal D haplotype carried the HLA antigens HLA Aw34, B27, DR1, and MT2. The affected daughter inherited the paternal haplotype Al, B8, CW3, DR3, and MT2. The affected members in this family, as in the previous families, typed for the MT1 determinant on one haplotype and the MT2 determinant on the other haplotype. None of the disease-free individuals in this family had this combination of antigens.
HLA DR antigens in Sjogren's syndrome 535 MT1 appears to be associated with Ss and infrequent in the Ss-RA group, the difference in frequency being statistically significant.
The combination of DR3 and DR4 was unique to the Ss-RP group. The results show that this group of patients shares antigenic determinants, one of which is common to each of the other groups.
The common increase of the antigen frequency of MT2 together with different DR determinants in these 3 patient groups that have a common disease manifestation suggests the possibility that gene interaction may play an important role in disease manifestation. This concept has been suggested by Svejgaard et The HLA DR3 antigen association with Ss is well documented. In addition we previously reported an increase in the DR4 antigen frequency (and decrease in DR3) in patients with Ss-RA. 3 We now report an increased frequency of both HLA DR3 and HLA DR4 in patients with Ss-RP.
The recently described MT2 antigen was found with a relatively high frequency in all 3 patient groups. This increase is significantly different from an antigen frequency of 53%, which was found in 205 normal Caucasians in our laboratory (Ss, p<002; Ss-RP, p<0008; Ss-RA, p<002). Comparison of the total frequency of MT2 in the 3 groups with the normal antigen frequency also demonstrated significant differences (p<0-001). It would appear, therefore, that MT2 is the most frequent antigen controlled by the human major histocompatibility complex that is associated with Sjogren's syndrome regardless of other disease manifestations. 
